Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SSRI + placebo
DRUG
3 trials
Sponsors
National Institute of Mental Health (NIMH)
, Shanghai Mental Health Center
, Faculty of Medicine, Ain Shams University
Conditions
Major Depressive Disorder
Mental and Behavioural Disorders Depression
Phase 4
Combining Medications to Enhance Depression Outcomes
Completed
NCT00590863
National Institute of Mental Health (NIMH)
Major Depressive Disorder
Start: 2008-03-31
End: 2009-09-30
Updated: 2014-04-23
Unknown Phase
Pentoxifylline as an add on to SSRIs
Recruiting
PACTR201008000246399
Faculty of Medicine, Ain Shams University
Mental and Behavioural Disorders Depression
Start: 2010-07-01
Target: 40
Updated: 2026-09-14
PKC as Serum Biomarkers for Depression
NCT04531423
Shanghai Mental Health Center
Major Depressive Disorder
Start: 2020-10-01
End: 2022-09-30
Target: 100
Updated: 2020-08-28
Related Papers
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.
2017-01-24
150 citations
Cross-trial prediction of treatment outcome in depression: a machine learning approach.
2016-01-21
434 citations
Relationship Between Obesity and Depression
Psychosomatic Medicine
2013-10-26
59 citations
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
2012-05-29
19 citations
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
2011-10-01
39 citations